Abstract
This study assesses HIV and hepatitis C testing and treatment availability in US specialty substance use disorder treatment facilities that offered medication for opioid use disorder in 2017-2020, stratified between federally certified Opioid Treatment Programs (OTPs) and non-OTPs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have